LITMOTEF Trademark

Trademark Overview


On Friday, October 15, 2021, a trademark application was filed for LITMOTEF with the United States Patent and Trademark Office. The USPTO has given the LITMOTEF trademark a serial number of 97076787. The federal status of this trademark filing is REGISTERED as of Tuesday, November 15, 2022. This trademark is owned by Glaxo Group Limited. The LITMOTEF trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
litmotef

General Information


Serial Number97076787
Word MarkLITMOTEF
Filing DateFriday, October 15, 2021
Status700 - REGISTERED
Status DateTuesday, November 15, 2022
Registration Number6899768
Registration DateTuesday, November 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2022

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Tuesday, November 15, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 15, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 30, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 27, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, July 27, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 27, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, July 27, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, July 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 21, 2022NON-FINAL ACTION E-MAILED
Thursday, July 21, 2022NON-FINAL ACTION WRITTEN
Thursday, July 21, 2022ASSIGNED TO EXAMINER
Thursday, November 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 19, 2021NEW APPLICATION ENTERED IN TRAM